MEDICINES DISCOVERY CATAPULT SERVICES LIMITED
Company Information
- Company Number
- 10305216
- Registered Address
- C/O Mazars Llp, 1st Floor, Two Chamberlain Square, Birmingham, B3 3AX
- Status
- Liquidation
- Employee Count
- 432
- Turnover
- £109,016,000
- EBITDA
- £43,975,000
Additional Details
- Company Type
- Private limited Company
- Incorporated On
- 1 August 2016
- Nature of Business
- 72190 - Other research and experimental development on natural sciences and engineering
- Industries
- Coming Soon
- Region
- West Midlands
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Oct 2021 - 31 Mar 2022 | 21 Apr 2022 | 14 | 98% | 2% | 0% | 0% |
| 01 Apr 2021 - 30 Sept 2021 | 28 Oct 2021 | 14 | 88% | 10% | 2% | 2% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
30 days from invoice date
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
N/A
Maximum contractual payment period agreed
60
Dispute Resolution Process
All disputes should be sent to financelhl@md.catapult.org.uk and will be responded to within 24 hours
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
MEDICINES DISCOVERY CATAPULT SERVICES LIMITED is a leading organization in the field of healthcare and pharmaceutical research and development. They are committed to driving innovation in the discovery and development of new medicines, with a focus on sustainability and ethical practices.
Their sustainability program includes initiatives such as reducing their carbon footprint, promoting responsible waste management, and supporting ethical sourcing of materials. They also prioritize diversity and inclusion in their workforce and strive to create a positive impact on the communities they serve.
The company offers a range of services to support the development of new medicines, including drug discovery and development, data analysis, and clinical trial management. They work closely with industry partners, academic institutions, and government agencies to drive collaboration and accelerate the development of life-saving drugs.
Key people at MEDICINES DISCOVERY CATAPULT SERVICES LIMITED include their CEO, Dr. Ian Campbell, and their Chief Scientific Officer, Dr. Melanie Lee. Both bring a wealth of experience and expertise to the company, ensuring their position as a leader in the field of medicines discovery.
Contact information for MEDICINES DISCOVERY CATAPULT SERVICES LIMITED can be found on their website, including their registered office address in London, UK. Their website also provides detailed information on their services, sustainability program, and key personnel.
